Patricia Kaaijk Selected Research

Mumps Vaccine (Vaccine, Mumps)

1/2022	Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults.
1/2015	Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Kaaijk Research Topics

Disease

10	Mumps 01/2022 - 01/2015
6	Infections 12/2021 - 01/2016
3	Rubella (German Measles) 01/2022 - 01/2016
3	Measles 01/2022 - 01/2016
2	Breakthrough Infections 01/2022 - 11/2020
2	COVID-19 01/2022 - 11/2020
2	Meningococcal Infections 01/2014 - 02/2013
2	Neoplasms (Cancer) 07/2005 - 02/2003
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2018
1	Lyme Disease (Disease, Lyme) 01/2016
1	Leukemia 01/2006
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2006
1	Hypoxia (Hypoxemia) 03/2003
1	Glioma (Gliomas) 03/2003
1	Brain Neoplasms (Brain Tumor) 02/2003
1	Medulloblastoma 02/2003

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2022 - 02/2013
4	AntibodiesIBA 01/2022 - 01/2015
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2015
4	EpitopesIBA 12/2021 - 01/2019
3	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 11/2020 - 01/2016
2	Mumps Vaccine (Vaccine, Mumps)IBA 01/2022 - 01/2015
2	AntigensIBA 01/2022 - 07/2005
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
1	Neutralizing AntibodiesIBA 01/2022
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2021
1	HLA-A Antigens (HLA-A)IBA 01/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	NucleoproteinsIBA 01/2019
1	OspA proteinIBA 01/2016
1	Conjugate VaccinesIBA 01/2014
1	Polysaccharides (Glycans)IBA 01/2014
1	fludarabineIBA 01/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	Cladribine FDA LinkGeneric 01/2006
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2005
1	AutoantigensIBA 07/2005
1	Carcinoembryonic AntigenIBA 07/2005
1	Biological FactorsIBA 03/2003

Therapy/Procedure

1	Immunotherapy 07/2005
1	Combined Modality Therapy 02/2003
1	Radiotherapy 02/2003
1	Drug Therapy (Chemotherapy) 02/2003